HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrapleural alteplase in a patient with complicated pleural effusion.

AbstractOBJECTIVE:
To report the intrapleural use of alteplase in a patient diagnosed with complicated pleural effusion (CPE).
CASE SUMMARY:
A 62-year-old white woman admitted with respiratory distress and hypotension developed a right-sided multi-loculated pleural effusion. Thoracentesis and chest tube drainage were not successful in resolving the effusion. In an attempt to increase the drainage of the pleural effusion, alteplase 16 mg was administered into the pleural cavity via the chest tube on 6 consecutive days. As a result, the volume drained from the patient's chest tube increased, there was improvement on the chest X-ray, and she did not require surgical intervention.
DISCUSSION:
While streptokinase and urokinase have been shown to be useful adjuncts to chest tube drainage in the treatment of complicated pleural effusion and empyema, there have been no reports on the use of intrapleural alteplase. This report demonstrates that intrapleural administration of alteplase is a useful adjunct to tube drainage in resolving CPE.
CONCLUSIONS:
This patient's CPE resolved when intrapleural alteplase was used as an adjunct to chest tube drainage and antibiotics. Controlled trials need to be conducted to investigate fully the efficacy, dosing, and safety of intrapleural alteplase in the treatment of patients with CPE and empyema.
AuthorsCharlotte A Walker, Mary Beth Shirk, Marva M Tschampel, James A Visconti
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 37 Issue 3 Pg. 376-9 (Mar 2003) ISSN: 1060-0280 [Print] United States
PMID12639166 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator
Topics
  • Drug Administration Schedule
  • Fatal Outcome
  • Female
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Humans
  • Instillation, Drug
  • Middle Aged
  • Pleural Effusion (drug therapy)
  • Tissue Plasminogen Activator (administration & dosage, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: